Carpenter Consulting Corporation, United States
After more than 20 years contributing to the world’s leading stem cell research companies, Dr. Melissa Carpenter founded Carpenter Group Consulting in 2008. Throughout her distinguished career, she has made many significant contributions to stem cell research and therapy development. From exploring new technologies and translating them into therapies to navigating complex regulatory hurdles, Dr. Melissa Carpenter’s stem cell experience is as broad as it is deep. She is a pioneer in the human embryonic stem cell (hESC) research field and is one of the few practicing professionals with a background in this highly specialized industry. Dr. Carpenter has held leadership positions at CytoTherapeutics, Inc., Geron Corporation and Novocell, Inc., where she built critical therapy development programs from the ground up. Under her leadership, the companies realized significant innovations, many of which are moving ever closer to becoming approved regenerative therapies.
CAREER PLURIPOTENCY: PIONEERING PATHS IN ACADEMIC AND NON-ACADEMIC SECTORS
Wednesday, July 10, 2024
4:00 PM – 5:30 PM CEST